Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureRajsavi Anand, Andres J Yarur
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The clinical significance of serum C reactive protein levels in Crohn’s disease. Results of a prospective longitudinal study
10.1097/00004836-198808000-00011 · 1988
Usefulness of C-reactive protein as a disease activity marker in Crohn’s disease according to the location of disease
10.5009/gnl13424 · 2015
Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn’s disease activity
10.1002/jgh3.12068 · 2018
Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn’s disease?: a systematic review
10.5217/ir.2018.00114 · 2019
Diagnostic accuracy of fecal calprotectin for the detection of small bowel Crohn’s disease through capsule endoscopy: an updated meta-analysis and systematic review
10.5009/gnl20249 · 2021
AGA clinical practice guideline on the role of biomarkers for the management of Crohn’s disease
10.1053/j.gastro.2023.09.029 · 2023
STRIDE-II: An update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD
10.1053/j.gastro.2020.12.031 · 2021
Comparative efficiency of leucine-rich alpha-2 glycoprotein and fecal calprotectin to assess endoscopic activity in Crohn’s disease: a prospective observational study
10.1093/ibd/izag105 · 2026
Leucine-rich alpha-2 glycoprotein is a serum biomarker of mucosal healing in ulcerative colitis
10.1093/ecco-jcc/jjw132 · 2017
Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis
10.1002/ibd.22936 · 2012
Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease
10.1038/s41598-021-90441-x · 2021
Serum leucine-rich α2 glycoprotein: a novel biomarker for small bowel mucosal activity in Crohn’s disease
10.1016/j.cgh.2021.06.036 · 2022
Unresolved referenced work
Kept as external metadata until matched
Faecal calprotectin
2018
Compliance with the faecal calprotectin test in patients with inflammatory bowel disease
10.1177/2050640616686517 · 2017
No additional external references are available.